Latest in News & Research

Dupilumab Eases Atopic Dermatitis in Children Younger Than 6 Years

Signs and symptoms of atopic dermatitis improved with dupilumab versus placebo in addition to topical corticosteroids

By Physician’s Briefing Staff | | September 19, 2022

Is Efficacy of Itraconazole for Tinea Corporis/Cruris Higher With Greater Dose?

400-mg dose of itraconazole achieves higher cure rate, but cost is 120 percent greater compared with 100-mg dose

By Dermsquared Editorial Team | | September 14, 2022

Few Europeans Use Photoprotection All Year Round

Only 56 percent of Europeans were aware that sun protection is useful when weather is overcast

By Dermsquared Editorial Team | | September 14, 2022

Causal Effect ID'd for IBD With Psoriasis, Psoriatic Arthritis

Crohn disease, but not ulcerative colitis, associated with psoriasis and psoriatic arthritis

By Physician’s Briefing Staff | | September 14, 2022

TikTok 'Slugging' Trend Has People Coating Their Faces With Grease

To slug or not to slug? That's the question for millions of TikTok users, who turn to the social media giant for tips and...

By Alan Mozes (HealthDay News) | | September 13, 2022

Cemiplimab Studied as Neoadjuvant Therapy for Cutaneous SCC

In phase 2 study, about half of patients with resectable stage II to IV cutaneous squamous cell carcinoma had pathological complete response

By Physician’s Briefing Staff | | September 12, 2022

FDA Approves Botox Competitor That Lasts Longer

Daxxify lasts longer than Botox, with about 80 percent of users seeing no or mild facial lines at four months after injection

By Physician’s Briefing Staff | | September 09, 2022

Early Postoperative Microneedling May Improve Surgical Scars

Daxxify lasts longer than Botox, with about 80 percent of users seeing no or mild facial lines at four months after injection

By Physician’s Briefing Staff | | September 09, 2022

Patients With Alopecia Areata Prefer Shared Decision-Making

Reduced decisional regret seen in association with incorporation of shared decision-making by physicians

By Dermsquared Editorial Team | | September 07, 2022

Two-Photon Fluorescence Microscopy Promising for Nonmelanoma Skin Cancer

TPFM has high sensitivity, specificity, accuracy for basal cell carcinoma, squamous cell carcinoma diagnosis

By Dermsquared Editorial Team | | September 07, 2022

FDA Approves SPEVIGO for Generalized Pustular Psoriasis Flares

The monoclonal antibody infusion is approved for use in adults

By Physician’s Briefing Staff | | September 06, 2022

Diagnosis of Psoriasis May Be Delayed in Primary Care

Medical records of psoriasis patients show reports of symptoms suggestive of psoriasis five years before diagnosis

By Physician's Briefing Staff | | September 06, 2022

Genetic Spectrum of Uncombable Hair Syndrome Described

Pathogenic variants discovered in

By Dermsquared Editorial Team | | August 31, 2022

How Does Microneedling Compare to Chemical Peeling for Acne Scars?

Treatment efficacy superior for patients receiving microneedling versus 35 percent glycolic acid peels every two weeks

By Dermsquared Editorial Team | | August 31, 2022

Study Aims to Identify Melanoma Patients With High-Risk Disease

Patients with AJCC IIIA and sentinel node metastatic tumor deposits ≥0.3 mm have lower five-year disease-specific survival rates

By Physician’s Briefing Staff | | August 31, 2022

Tecovirimat Well Tolerated for Treatment of Monkeypox

By day 21, 23 of 25 patients had resolution of lesions and pain; none of the patients discontinued treatment

By Physician’s Briefing Staff | | August 26, 2022

Is VTE Risk Increased With Atopic Dermatitis, JAK Inhibitor Use?

Systematic review, meta-analysis show no increased incidence of venous thromboembolism in patients with atopic dermatitis, treatment with JAK inhibitors

By Dermsquared Editorial Team | | August 24, 2022

Features of Congenital Nail Matrix Nevi Similar to Adult Subungual Melanoma

Congenital and congenital-type nail matrix nevi predominantly display irregular pattern of longitudinal microlines

By Dermsquared Editorial Team | | August 24, 2022

Sun Protection Low Among American Indians/Alaskan Natives

Lower hat use, sunscreen use reported, in addition to more frequent use of indoor tanning

By Physician’s Briefing Staff | | August 23, 2022

Gradient-Boosted Decision Trees Predict Treatment Success for Psoriasis

Gradient-boosted decision trees perform better than logistic regression for predicting biologic therapy leading to treatment duration of at least three years

By Dermsquared Editorial Team | | August 17, 2022

Guidance Developed for Use of Laser-Assisted Drug Delivery

Key findings that informed guidelines include that LADD is safe for adults, adolescents, immunosuppressed patients

By Dermsquared Editorial Team | | August 17, 2022

Prior Diagnoses Influence Dermatopathologists' Interpretations

Prior diagnoses swayed dermatopathologists from correct diagnosis to incorrect diagnosis in the interpretation of melanocytic lesions

By Physician’s Briefing Staff | | August 17, 2022

Comorbidities Up Among Patients With ESRD, Concomitant Psoriasis

Patients with end-stage renal disease and psoriasis are younger, more often obese, and more often have cancer, diabetes, CAD

By Physician’s Briefing Staff | | August 17, 2022

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026